Mengyu Zhu

Munich, BY, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis.

Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis.

Journal: Circulation

Published: April 07, 2026

Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis.

Mir147 Limits the Contribution of Non-Foamy Macrophages to Atherosclerosis.

Journal: Circulation

Published: April 07, 2026

Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.

Persistent symptoms and clinical findings in adults with post-acute sequelae of COVID-19/post-COVID-19 syndrome in the second year after acute infection: A population-based, nested case-control study.

Journal: PLoS medicine

Published: June 10, 2024

Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice.

Endothelial ENPP2 (Ectonucleotide Pyrophosphatase/Phosphodiesterase 2) Increases Atherosclerosis in Female and Male Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: June 16, 2022

MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions.

MicroRNA-21 Controls Circadian Regulation of Apoptosis in Atherosclerotic Lesions.

Journal: Circulation

Published: July 08, 2021

Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism.

Dicer in Macrophages Prevents Atherosclerosis by Promoting Mitochondrial Oxidative Metabolism.

Journal: Circulation

Published: May 12, 2018

Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer.

Macrophage MicroRNAs as Therapeutic Targets for Atherosclerosis, Metabolic Syndrome, and Cancer.

Journal: International journal of molecular sciences

Published: May 02, 2018

miR-103 promotes endothelial maladaptation by targeting lncWDR59.

miR-103 promotes endothelial maladaptation by targeting lncWDR59.

Journal: Nature communications

Published: October 19, 2017

Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by Targeting Mafb.

Hyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by Targeting Mafb.

Journal: Diabetes

Published: March 13, 2017

Corrigendum: Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4.

Corrigendum: Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4.

Journal: Nature communications

Published: June 09, 2016

Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4.

Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4.

Journal: Nature communications

Published: October 26, 2015

Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.

Regulation of Csf1r and Bcl6 in macrophages mediates the stage-specific effects of microRNA-155 on atherosclerosis.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: March 27, 2015

Showing 1-12 of 14

Last Updated: 09/26/2026